Prof. William N. Rom

NYU School of Medicine, USA

Email: [email protected]

Qualifications

1971 M.D., University of Minnesota, USA, Medicine

1967 B.A., University of Colorado, USA, Political Science

Publications (selected)

1. Ringen, K., Frank, A., & Rom, W. (2026). Sheldon W. Samuels, A Champion of Air Pollution Control and Worker Health. American Journal of Industrial Medicine, 69(2), 79–81.
2. Samuels, S. W., Ringen, K., Rom, W. N., et al. (2022). Ethical thinking in occupational and environmental medicine: Commentaries from the Selikoff Fund for Occupational and Environmental Cancer Research. American Journal of Industrial Medicine, 65(4), 286–320.
3. Tsay, J. C. J., Wu, B. G., Sulaiman, I., et al. (2021). Lower Airway Dysbiosis Affects Lung Cancer Progression. Cancer Discovery, 11(2), 293–307.
4. Tsay, J. C. J., Hu, Y. J., Goldberg, J. D., et al. (2020). Value of metalloproteinases in predicting COPD in heavy urban smokers. Respiratory Research, 21(1), Article 228.
5. Balasubramaniapandian, C., Vijayalekshmy, S., Yie, T., et al. (2020). Change in Matrix Metalloproteinases (MMP) Level Differs Between Asymptomatic Patients with and Without Emphysema. American Journal of Respiratory and Critical Care Medicine, 201, Abstract A7156.
6. Han, J., Duenas, S., Rom, W. N., et al. (2020). Measuring Autoimmune Response Against Tumor-Associated Antigens KOC and RalA to Prognosticate Long-Term Lung Cancer Survival. American Journal of Respiratory and Critical Care Medicine, 201, Abstract A4458.
7. El-Ashmawy, M., Wu, B., Tsay, J. C., et al. (2019). Host transcriptomic signatures associated with dysbiosis in a preclinical model of lung cancer. Journal of Clinical Oncology, 37(15_suppl), Abstract 3107.
8. Gershner, K., Olsen, E., Schluger, R., et al. (2019). Transcriptomic Signatures in Airway Brushings and Lung Cancer Prognosis. American Journal of Respiratory and Critical Care Medicine, 199, Abstract A5813.
9. Kossenkov, A. V., Qureshi, R., Dawany, N. B., et al. (2019). A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT. Cancer Research, 79(1), 263–273.
10. Kwok, B., Chiang, V., Thomas, S., et al. (2019). Utility of Regional Airway Epithelial Cells for Lung Cancer Biomarker. American Journal of Respiratory and Critical Care Medicine, 199, Abstract A5815.
11. Ooki, A., Dinalankara, W., Marchionni, L., et al. (2018). Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma. Oncogene, 37(45), 5967–5981.
12. Tsay, J. C. J., Wu, B. G., Badri, M. H., et al. (2018). Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. American Journal of Respiratory and Critical Care Medicine, 198(9), 1188–1198.
13. Weng, M. W., Lee, H. W., Park, S. H., et al. (2018). Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America, 115(27), E6152–E6161.
14. Morris, S., Vachani, A., Pass, H. I., et al. (2018). Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer. International Journal of Cancer, 142(11), 2355–2362.
15. Chiang, V., Lee, M. H., Yie, T., et al. (2018). FOXP3 Serum Concentrations in Subjects with Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, and High Risk Smokers. American Journal of Respiratory and Critical Care Medicine, 197, Abstract A4696.
16. Vijayalekshmy, S., Tsay, J., Jia, X., et al. (2018). MMP-7 Levels Is Associated with Emphysema and Airway Obstruction. American Journal of Respiratory and Critical Care Medicine, 197, Abstract A3133.
17. Ooki, A., Maleki, Z., Tsay, J. C. J., et al. (2017). A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA. Clinical Cancer Research, 23(22), 7141–7152.
18. Chang, J., Laboe, C., Draine, M., et al. (2017). Fifteen-Year Follow-Up of the NYU Lung Biomarker Screening Cohort: Indolent-Prevalent Screen-Detected Lung Cancers Demonstrate a Less Aggressive Form of Pulmonary Malignancy. Chest, 152(4_suppl), 626A.
19. Laboe, C., Lee, M., Gopisetti, N., et al. (2017). Mixed Panel Biomarkers for Early Diagnosis of Lung Cancer. Chest, 152(4_suppl), 622A.
20. Birse, C. E., Tomic, J. L., Pass, H. I., et al. (2017). Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules. Clinical Proteomics, 14, Article 25.

Profile Details

https://nyulangone.org/doctors/1750412326/william-n-rom
https://www.researchgate.net/profile/Wi
https://en.wikipedia.org/wiki/William_N._Romlliam-Rom-2

WOS ResearcherID: CCI-0573-2022